Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
8 May 2025
Adequate mitomycin C can effectively reduce recurrence and progression in patients with IR NMIBC – the value of maintenance therapy*
This episode explores the treatment of patients with intermediate-risk non-muscle-invasive bladder cancer (IR NMIBC), an important topic…
8 May 2025
Semaglutide Shows Promise in Treating MASH and Liver Fibrosis
Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.
8 May 2025
New Screening Model Enhances Hepatitis Care Access: EASL 2025
The study concludes that decentralised and person-centred hepatitis screening is effective and essential.
7 May 2025
Improving Bedside Nursing With ISBAR Communication
Improving communication between nurses is critical to patient safety and care quality, particularly in complex specialties like rheumatology and immunology.
7 May 2025
Exploring JAK Inhibitors for Safer, More Effective Vitiligo Treatment
New analysis shows promising repigmentation with JAK inhibitors in vitiligo, especially in combination with UVB. Safety and long-term outcomes remain key research needs.
BMS names Cari Gallman as new General Counsel
Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 years.
7 May 2025
Restoring T Cell Autophagy Reduces Liver Fibrosis Progression
A new study sheds light on the role of CD4 T cell autophagy, a cellular recycling process, in the progression of liver fibrosis.
7 May 2025
CMV After Transplant: Could Targeted T-Cell Therapy Change the Game?
New research explores how virus-specific T-cell therapy may help prevent or treat cytomegalovirus after transplant, revealing high response rates in HSCT patients but limited data in solid organ recipients.
7 May 2025
AI Enhances Fracture Risk Prediction in Women Who Are Postmenopausal: WCO 2025
Researchers from the OsteoLaus cohort have developed a machine learning model to predict fragility fractures in postmenopausal women using bone and body composition data.
7 May 2025
New Driver of Inflammation Found in Ulcerative Colitis
Clinically, this discovery could reshape the understanding of immune regulation in ulcerative colitis.
←
1
2
3
…
13
14
15
16
17
18
19
…
1,148
1,149
1,150
→
We’ve noticed you’re accessing
from
North/South America.
View
View